Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1BT----[3] 96, 97, 98 💬
2BT-11----[2] 96, 97 💬
3BT-11 (1000 mg)----[1] 97 💬
4BT-11 (500 mg)----[1] 97 💬
5BT-11 (Omilancor)----[1] 96 💬
6BT-11 1,000 mg----[1] 96 💬
7BT-11 1000mg----[3] 96, 97, 98 💬
8BT-11 500 mg----[2] 96, 97 💬
9BT-11 500mg----[1] 98 💬
10BT-11 Active----[2] 96, 97 💬
11BT051 200 mg----[1] 97 💬
12BT051 3200 mg----[1] 97 💬
13BT051 800 mg----[1] 97 💬
14BT061----[1] 46 💬
15BT061 (CD4 monoclonal antibody)----[1] 46 💬
16BT063----[1] 49 💬
17BT090----[1] 65 💬
18BT524----[1] 65 💬
19BT595----[2] 63, 65 💬
20BT681----[1] 65 💬
21BT971----[1] 46 💬
22BTK Inhibitor----[3] 46, 53, 160 💬
23BTRX-246040[1] BTRX-246040 (BTRX-246040)---[1] 6 💬
24BTT-1023----[1] 46 💬
25BTT1023----[1] 94 💬
26BTT1023 IV Infusion 20 mg/mL, 5 mL Drug Product----[1] 94 💬
27BTX-A[1] Botulinum toxin type A (BTX-A)[1] Botulinum toxin type A 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 6 💬
28Bupivacaine, triamcinolone, and heparin (BTH)[3] Bupivacaine,
Heparin,
Triamcinolone		[3] Triamcinolone ,
Adomiparin ,
Bupivacaine 💬 		[7] NR3C1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SERPINC1 💬 		[5] Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction 💬[1] 226 💬
29Dysport® (Botulinumtoxin A (Btx A))[1] Botulinum toxin type A (BTX-A)[1] Botulinum toxin type A 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 36 💬
30IgG Next Generation (BT595)----[1] 65 💬
31Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología PRGF-System (BTI)----[1] 96 💬